I hardly think a 1st quarter cash flow similar to 4th quarter would be disappointing. Keep in mind, OGC adjusted cash cost per ounce in the 4th quarter, resulting in a deceptive $310 cash cost per ounce. I feel the accurate accounting treatment would have been to recognize those two adjustments over the whole year, but I assume it is the auditors who identified it and rarely will companies make prior period restatements for unaudited interims in their MDA disclosures - confusing and probably not neccessary. That being said, $20 million in cash flow would be fantastic, because if you use the roughly $400 cash cost prior to adjustments in fourth quarter, you reduce cash flow to about $15 million range.
- Forums
- ASX - By Stock
- OGC
- running the numbers
running the numbers, page-6
-
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OGC (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online